⌘K
Loading ticker…
As of 2026-08-25, Harvard Bioscience Inc (HBIO) has a 3-month relative strength percentile of 89 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.1%, relative volume 0.29×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
HBIO is held by 2 ETFs as of Apr 2026. Top owner: DFAS at 0.00% weight, $9K notional.
Held by 4 ETFs · $811K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFASDimensional U.S. Small Cap ETF | 0.00% | $9K | new |
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $7K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HBIO Jan avg: -13.56% median: -18.36% win: 25% σ: 14.46% n: 4 2022-04-12 → 2026-07-31 | HBIO Feb avg: -8.69% median: -3.31% win: 25% σ: 30.55% n: 4 2022-04-12 → 2026-07-31 | HBIO Mar avg: -1.80% median: -11.36% win: 25% σ: 35.79% n: 4 2022-04-12 → 2026-07-31 | HBIO Apr avg: 0.86% median: -9.91% win: 40% σ: 31.59% n: 5 2022-04-12 → 2026-07-31 | HBIO May avg: -5.19% median: -7.84% win: 20% σ: 22.80% n: 5 2022-04-12 → 2026-07-31 | HBIO Jun avg: -2.78% median: -1.79% win: 20% σ: 5.36% n: 5 2022-04-12 → 2026-07-31 | HBIO Jul avg: 1.11% median: 4.44% win: 60% σ: 10.29% n: 5 2022-04-12 → 2026-07-31 | HBIO Aug avg: -5.28% median: -7.58% win: 25% σ: 8.26% n: 4 2022-04-12 → 2026-07-31 (current) | HBIO Sep avg: -10.73% median: -9.01% win: 0% σ: 8.61% n: 4 2022-04-12 → 2026-07-31 | HBIO Oct avg: 3.09% median: 3.59% win: 75% σ: 12.50% n: 4 2022-04-12 → 2026-07-31 | HBIO Nov avg: 8.28% median: -3.90% win: 25% σ: 26.05% n: 4 2022-04-12 → 2026-07-31 | HBIO Dec avg: 4.40% median: 2.06% win: 50% σ: 16.41% n: 4 2022-04-12 → 2026-07-31 |